美國境內滿$49+包郵

Lifeflower® 燈盞花素

Lifeflower® 支持腦部及腦血管健康

Product Details

BRE-002 Lifeflower® 燈盞花素 (野黄芩苷 ≥98%, HPLC)

BRE-003 Lifeflower® 燈盞花素 (野黄芩苷 ≥90%, HPLC)

分子式: C12H18O12

分子量: 462.36

CAS#: 116122-36-2

化學性質:膳食補充劑原料

通用名稱: Erigeron Breviscapus Extract, Scutellarin, Breviscapinum

質量控制 全程溯源

  • GAP種植基地
  • cGMP生産基地
  • GSP物流與倉庫
  • 獨立檢測質量
  • 符合FDA規範

科學研究

請按此連結到 farlong.us 閲讀更多

我們可以提供以下測試報告

Jing Ma  2017a.  A Single Dose Toxicity Study of Breviscapine for Injection in Sprague Dawley Rats via Intravenous Injection.  Study No. 1610AD1.  Conducted at Shanghai InnoStar Bio-Tech Co., LTD. (InnoStar).  National Shanghai Center for New Drug Safety Evaluation and Research (NCDSER).  199 Guoshoujing Road, Pilot Free Trade Zone, Shanghai, Peoples Republic of China.  May 23, 2018, pp. 64. 

Jing Ma  2017b.  The toxicity test data and literature for rats with repeated administration.  The toxicity test on SD rats receiving 4-week repeated intravenous injection with breviscapine injection in 4-week recovery period.  Study No. 1016RD1.  Conducted at Shanghai InnoStar Bio-Tech Co., LTD. (InnoStar).  National Shanghai Center for New Drug Safety Evaluation and Research (NCDSER).  199 Guoshoujing Road, Pilot Free Trade Zone, Shanghai, Peoples Republic of China.  June 28, 2018, summary of test results, pp. 4. 

Jing Ma  2017c.  The toxicity test data and literature for Beagle dogs with repeated administration.  The toxicity test on Beagle dogs receiving 4-week repeated intravenous injection with breviscapine injection in the 4-week recovery period.  Study No. 1016RD2.  Conducted at Shanghai InnoStar Bio-Tech Co., LTD. (InnoStar).  National Shanghai Center for New Drug Safety Evaluation and Research (NCDSER).  199 Guoshoujing Road, Pilot Free Trade Zone, Shanghai, Peoples Republic of China.  June 28, 2018, summary of test results, pp. 3. 

Jing Ma  2017d.  Test data and literature for anaphylactic (systemic) special safety.  Active systemic anaphylaxis test for guinea pigs with the administration of breviscapine injection.  Study No. 1610HY2.  Conducted at Shanghai InnoStar Bio-Tech Co., LTD. (InnoStar).  National Shanghai Center for New Drug Safety Evaluation and Research (NCDSER).  199 Guoshoujing Road, Pilot Free Trade Zone, Shanghai, Peoples Republic of China.  June 4, 2018, summary of test results, pp. 3. 

Jing Ma  2017e.  Test data and literature for the special safety of hemolysis.  Hemolysis test for the breviscapine injection.  Study No. 1610HL1.  Conducted at Shanghai InnoStar Bio-Tech Co., LTD. (InnoStar).  National Shanghai Center for New Drug Safety Evaluation and Research (NCDSER).  199 Guoshoujing Road, Pilot Free Trade Zone, Shanghai, Peoples Republic of China.  May 14, 2018, summary of test results, pp. 2. 

Jing Ma  2017f.  The toxicity test data and literature for rats with repeated administration.  The toxicity test on SD rats receiving 4-week repeated intravenous injection with breviscapineinjection in 4-week recovery period with micronucleus test.  Study No. 1016RD1.  Conducted at Shanghai InnoStar Bio-Tech Co., LTD. (InnoStar).  National Shanghai Center for New Drug Safety Evaluation and Research (NCDSER).  199 Guoshoujing Road, Pilot Free Trade Zone, Shanghai, Peoples Republic of China.  June 28, 2018, summary of test results, pp. 4. 

Jing Ma  2017g.  Test data and literature of genetic toxicity.  Bacterial reverse mutation test for the breviscapine injection.  Study No. 1610AM1.  Conducted at Shanghai InnoStar Bio-Tech Co., LTD. (InnoStar).  National Shanghai Center for New Drug Safety Evaluation and Research (NCDSER).  199 Guoshoujing Road, Pilot Free Trade Zone, Shanghai, Peoples Republic of China.  April 19, 2018, summary of test results, pp. 2. 

Jing Ma  2017h.  Genetic toxicity test data and literature.  The micronucleus test on SD rats receiving intravenous injection with breviscapine injection.  The accompanied toxicity test on SD rats receiving 4-week repeated intravenous injection with breviscapine injection in 4-week recovery period.  Study No. 1610RD1.  Conducted at Shanghai InnoStar Bio-Tech Co., LTD. (InnoStar).  National Shanghai Center for New Drug Safety Evaluation and Research (NCDSER).  199 Guoshoujing Road, Pilot Free Trade Zone, Shanghai, Peoples Republic of China.  June 28, 2018, summary of test results, pp. 2. 

Jing Ma  2017i.  Test data and literature of genetic toxicity.  The chromosome aberration test on Chinese hamster lung fibroblast cell line for the breviscapine injection.  Study No. 1016CA1.  Conducted at Shanghai InnoStar Bio-Tech Co., LTD. (InnoStar).  National Shanghai Center for New Drug Safety Evaluation and Research (NCDSER).  199 Guoshoujing Road, Pilot Free Trade Zone, Shanghai, Peoples Republic of China.  April 9, 2018, summary of test results, pp. 3. 

Jing Ma  2017j.  Test data and literature for genetic toxicity.  The comet assay on SD rats receiving the intravenous injection with breviscapine injection.  Study No. 1610CO1.  Conducted at Shanghai InnoStar Bio-Tech Co., LTD. (InnoStar).  National Shanghai Center for New Drug Safety Evaluation and Research (NCDSER).  199 Guoshoujing Road, Pilot Free Trade Zone, Shanghai, Peoples Republic of China.  July 6, 2018, summary of test results, pp. 3. 

Jing Ma  2017k.  Test data and literature for reproductive toxicity.  The toxicity test of reproduction and early embryonic development for SD rats receiving the intravenous injection with breviscapine injection.  Study No. 1610RA1.  Conducted at Shanghai InnoStar Bio-Tech Co., LTD. (InnoStar).  National Shanghai Center for New Drug Safety Evaluation and Research (NCDSER).  199 Guoshoujing Road, Pilot Free Trade Zone, Shanghai, Peoples Republic of China.  March 14, 2018, summary of test results, pp. 3. 

Jing Ma  2017l.  Test data and literature for special safety of local irritation.  The irritation test on administration sites of Beagle dogs receiving intravenous injection with breviscapine injection.  The accompanied toxicity test on Beagle dogs receiving 4-week repeated intravenous injection with breviscapine injection in 4-week recovery period.  Study No. 1016RD2.  Conducted at Shanghai InnoStar Bio-Tech Co., LTD. (InnoStar).  National Shanghai Center for New Drug Safety Evaluation and Research (NCDSER).  199 Guoshoujing Road, Pilot Free Trade Zone, Shanghai, Peoples Republic of China.  March 14, 2018, summary of test results, pp. 2. 

Jing Ma  2017m.  Test data and literature for anaphylactic (systemic) special safety.  The passive cutaneous anaphylaxis test for rats receiving the breviscapine injection.  Study No. 1016HY4.  Conducted at Shanghai InnoStar Bio-Tech Co., LTD. (InnoStar).  National Shanghai Center for New Drug Safety Evaluation and Research (NCDSER).  199 Guoshoujing Road, Pilot Free Trade Zone, Shanghai, Peoples Republic of China.  June 4, 2018, summary of test results, pp. 3. 

立即訂購

如需訂購我們的原料,請致電1-888-327-5664,發送電子郵件至social@farlong.com或填寫下面的表格。